Dlouhý Martin, Havlík Pavel
Faculty of Informatics and Statistics, Prague University of Economics and Business, 4 Winston Churchill Sq, Prague, Czech Republic.
Faculty of Finance and Accounting, Prague University of Economics and Business, 4 Winston Churchill Sq, Prague, Czech Republic.
Health Econ Rev. 2024 Jul 29;14(1):59. doi: 10.1186/s13561-024-00538-y.
Policymakers, who are constantly discussing growing health expenditures, should know whether the health system is efficient. We can provide them with such information through international health system efficiency evaluations. The main objectives of this study are: (a) to evaluate the efficiency of health systems in 28 developed countries by multiple-criteria decision analysis (MCDA) and data envelopment analysis (DEA) and (b) to identify reasonable benchmark countries for the Czech Republic, for which we collect information on the relative importance of health system inputs and outputs.
We used MCDA and DEA to evaluate the efficiency of the health systems of 28 developed countries. The models included four health system inputs (health expenditure as a relative share of GDP, the number of physicians, nurses, and hospital beds) and three health system outputs (life expectancy at birth, healthy life expectancy, and infant mortality rate). The sample covers 27 OECD countries and Russia, which is also included in the OECD database. To determine the input and output weights, we used a questionnaire sent to health policy experts in the Czech Republic.
We obtained subjective information on the relative importance of the health system inputs and outputs from 27 Czech health policy experts. We evaluated health system efficiency using four MCDA and two DEA models. According to the MCDA models, Turkey, Poland, and Israel were found to have efficient health systems. The Czech Republic ranked 16th, 19th, 15th, and 17th. The benchmark countries for the Czech Republic's health system were Israel, Estonia, Luxembourg, Italy, the UK, Spain, Slovenia, and Canada. The DEA model with the constant returns to scale identified four technically efficient health systems: Turkey, the UK, Canada, and Sweden. The Czech Republic was found to be one of the worst-performing health systems. The DEA model with the variable returns to scale identified 15 technically efficient health systems. We found that efficiency results are quite robust. With two exceptions, the Spearman rank correlations between each pair of models were statistically significant at the 0.05 level.
During the model formulation, we investigated the pitfalls of efficiency measurement in health care and used several practical solutions. We consider MCDA and DEA, above all, as exploratory methods, not methods providing definitive answers.
决策者们一直在讨论不断增长的医疗支出,他们应该了解卫生系统是否高效。我们可以通过国际卫生系统效率评估为他们提供此类信息。本研究的主要目标是:(a)通过多标准决策分析(MCDA)和数据包络分析(DEA)评估28个发达国家卫生系统的效率;(b)为捷克共和国确定合理的基准国家,为此我们收集了有关卫生系统投入和产出相对重要性的信息。
我们使用MCDA和DEA评估28个发达国家卫生系统的效率。模型包括四个卫生系统投入(卫生支出占GDP的相对份额、医生数量、护士数量和病床数量)和三个卫生系统产出(出生时预期寿命、健康预期寿命和婴儿死亡率)。样本涵盖27个经合组织国家和俄罗斯,俄罗斯也包含在经合组织数据库中。为了确定投入和产出权重,我们向捷克共和国的卫生政策专家发送了一份问卷。
我们从27位捷克卫生政策专家那里获得了关于卫生系统投入和产出相对重要性的主观信息。我们使用四个MCDA模型和两个DEA模型评估了卫生系统效率。根据MCDA模型,发现土耳其、波兰和以色列的卫生系统高效。捷克共和国分别排名第16、19、15和17位。捷克共和国卫生系统的基准国家是以色列、爱沙尼亚、卢森堡、意大利、英国、西班牙、斯洛文尼亚和加拿大。具有规模报酬不变的DEA模型确定了四个技术上高效的卫生系统:土耳其、英国、加拿大和瑞典。捷克共和国被发现是表现最差的卫生系统之一。具有规模报酬可变的DEA模型确定了15个技术上高效的卫生系统。我们发现效率结果相当稳健。除了两个例外,每对模型之间的斯皮尔曼等级相关性在0.05水平上具有统计学意义。
在模型制定过程中,我们研究了医疗保健效率测量中的陷阱并采用了几种实际解决方案。我们尤其将MCDA和DEA视为探索性方法,而非提供确定性答案的方法。